Colchicine for Acute Gout
For an adult with acute gout and no renal or hepatic impairment, use low-dose colchicine: 1.2 mg at the first sign of flare, followed by 0.6 mg one hour later (total 1.8 mg over 1 hour). This regimen is FDA-approved and provides equivalent efficacy to older high-dose regimens while dramatically reducing gastrointestinal side effects 1.
Timing is Critical
Colchicine must be initiated within 12-36 hours of symptom onset to be effective 2, 3. The ACR guidelines specify colchicine is appropriate only if started within 36 hours 3, while EULAR recommends initiation within 12 hours 2. Earlier treatment yields better outcomes—this is why patient education about "pills in pocket" self-medication at first warning symptoms is emphasized 2, 4.
Why Low-Dose Works
The landmark 2010 trial definitively showed that low-dose colchicine (1.8 mg total over 1 hour) achieved 37.8% response rate versus 15.5% for placebo, with a safety profile indistinguishable from placebo 5. In contrast, high-dose colchicine (4.8 mg over 6 hours) caused diarrhea in 76.9% of patients (with 19.2% having severe diarrhea) and vomiting in 17.3%, despite similar efficacy 5. Higher doses are not more effective—they only increase toxicity 1, 5.
Dosing Algorithm
Standard dose (normal renal/hepatic function):
- 1.2 mg immediately, then 0.6 mg one hour later
- Do not repeat this treatment course for at least 3 days 1
- After 12 hours, may resume prophylactic dosing (0.6 mg once or twice daily) until flare resolves 3
If already on prophylactic colchicine:
- Choose alternative therapy (NSAID or corticosteroid) 3
- The evidence does not support adding acute treatment doses on top of prophylaxis
Critical Contraindications
Absolute contraindications:
- Concurrent use of strong CYP3A4 or P-glycoprotein inhibitors (clarithromycin, cyclosporine, ritonavir, ketoconazole, itraconazole) 2, 6, 1
- Severe renal impairment (CrCl <30 mL/min) without dose adjustment 2, 6
- Combined renal and hepatic impairment 1
Comparison to Alternatives
The 2017 ACP guidelines recommend corticosteroids, NSAIDs, or colchicine as first-line options, with corticosteroids preferred as first-line due to superior safety profile and lower cost 6. However, colchicine remains appropriate when:
- Corticosteroids are contraindicated (systemic fungal infection, uncontrolled diabetes)
- NSAIDs are contraindicated (renal disease, heart failure, GI bleeding risk)
- Patient presents early enough (<12-36 hours from onset)
All three options show similar efficacy for pain reduction in acute gout 6. The choice depends on contraindications, cost considerations, and patient-specific factors rather than superiority of one agent.
Common Pitfalls
Do not use traditional high-dose hourly regimens (0.6 mg every 1-2 hours until diarrhea or relief)—these are obsolete and dangerous 7, 5. The narrow therapeutic window of colchicine means even modest overdosing causes severe toxicity including fatal outcomes when combined with CYP3A4 inhibitors 3, 1.
Do not continue prophylactic colchicine during acute treatment if the patient is already taking it—switch to alternative therapy instead 3.
Do not use colchicine as an analgesic—it is anti-inflammatory only and should not treat pain from other causes 1.